Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis

Figure 3 Plasma and hepatic levels of iPF_2α-III and antioxidant enzymes in rats. (A) Significant differences in iPF_2α-III levels were found in the liver, but not in plasma between HF rats and control; (B) Significant decreases in SOD activity were found in the liver, but not in erythrocytes of HF rats compared to that in control, and (C) Reducing tendency of CAT activities was observed in liver, but not in blood of HF rats. ^bP < 0.01 and ^dP < 0.001.